Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
Thanks Sleven. I agree that we might | rosemountbomber | investorshub | 07/21/2024 11:02:36 PM |
RMB, It wouldn't surprise me to see a | Number sleven | investorshub | 07/21/2024 9:54:54 PM |
RMB, | Number sleven | investorshub | 07/21/2024 6:29:29 PM |
DAR, You read it correctly. | Number sleven | investorshub | 07/21/2024 6:23:14 PM |
Zip, I was wondering about something. First | rosemountbomber | investorshub | 07/21/2024 5:02:16 PM |
Its hard to say because in the US | CaptBeer | investorshub | 07/21/2024 3:19:06 PM |
What is the USA price reimbursement? | Denisk | investorshub | 07/21/2024 3:07:57 PM |
Hikma seems to be disregarding the Amarin | ziploc_1 | investorshub | 07/21/2024 2:23:49 PM |
NS, so if I read this correctly it | DAR53 | investorshub | 07/21/2024 1:10:43 PM |
Yep, It's the EPA! | CaptBeer | investorshub | 07/21/2024 12:23:31 PM |
Zip, Market cap is not a factor, of | Number sleven | investorshub | 07/21/2024 10:36:43 AM |
Zip, Nuke, | Number sleven | investorshub | 07/21/2024 10:13:38 AM |
https://x.com/MichaelPGannon1/status/1814648537856008490 | DMC8 | investorshub | 07/21/2024 8:03:38 AM |
No point in reading the board in the | The Canes | investorshub | 07/21/2024 2:00:29 AM |
Thank you for this great summary CaptI do | Chromosome | investorshub | 07/21/2024 1:58:14 AM |
Here's what we know so far: | CaptBeer | investorshub | 07/21/2024 12:53:55 AM |
Your favorite Nevada Judge is back in the | Tatsumaki | investorshub | 07/21/2024 12:29:58 AM |
zip; agreed damages should be at a minimum | Nukemtiltheyglow | investorshub | 07/20/2024 11:33:58 PM |
Denisk; You're correct of course, we don't know | Nukemtiltheyglow | investorshub | 07/20/2024 11:03:48 PM |
The amount that Hikma profited by infringing on | ziploc_1 | investorshub | 07/20/2024 9:15:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...